Anthony C. Hayes is the CEO of AIkido Pharma Inc., a NASDAQ-traded (ticker: AIKI) technology commercialization company. Hayes began his tenure by overseeing AIkido’s transformation from a biotechnology company into a diversified corporate entity, committed to advancing innovation by participating in the development of new technologies across several sectors.
As CEO, Hayes developed and implemented a strategic plan to advance AIkido’s mission and objectives and to significantly promote company growth. He identified and brought about multimillion-dollar M&A acquisitions that resulted in some of the largest transactions in technology patents. Hayes is also involved in all aspects of investor relations, representing AIkido in shareholder meetings, at domestic and international conferences, and in television and print media (such as Bloomberg Television and Forbes).
An attorney and former partner of an Am Law 100 firm, Hayes previously co-founded and was managing member of JaNSOME IP Management LLC, an intellectual property monetization firm. JaNSOME provided consulting and advisory services to individuals and companies on best practices for monetization of the asset class.
President George W. Bush gave Hayes special recognition for creating the Wills for Heroes program, a national 501(c)(3), in response to the September 11 attacks (willsforheroes.com). Other honors include IAM IP Personality of 2013, American Board of Trial Advocates Young Lawyer of the Year and “20 Under 40” in Columbia, South Carolina.
Education: Juris Doctor from Tulane University Law School (1995); Bachelor of Arts in economics from Mary Washington College (1990)
Bar Memberships: District of Columbia; Florida; New York; South Carolina
Publications: “Avoiding the Post-Crisis Crisis: How to Prevent Post-Crisis Donation for Victims from Leading to Litigation” (ICMA Journal, January/February 2008)
What is Anthony Hayes' net worth?
The estimated net worth of Anthony Hayes is at least $276,776.64 as of May 29th, 2024. Mr. Hayes owns 219,664 shares of AIkido Pharma stock worth more than $276,777 as of December 22nd. This net worth estimate does not reflect any other assets that Mr. Hayes may own. Additionally, Mr. Hayes receives a salary of $960,000.00 as CEO at AIkido Pharma. Learn More about Anthony Hayes' net worth.
How old is Anthony Hayes?
What is Anthony Hayes' salary?
How do I contact Anthony Hayes?
Has Anthony Hayes been buying or selling shares of AIkido Pharma?
Anthony Hayes has not been actively trading shares of AIkido Pharma within the last three months. Most recently, on Wednesday, December 14th, Anthony Hayes bought 4,500 shares of AIkido Pharma stock. The stock was acquired at an average cost of $3.69 per share, with a total value of $16,605.00. Following the completion of the transaction, the chief executive officer now directly owns 176,681 shares of the company's stock, valued at $651,952.89. Learn More on Anthony Hayes' trading history.